1. Home
  2. LGHL vs ADTX Comparison

LGHL vs ADTX Comparison

Compare LGHL & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGHL

Lion Group Holding Ltd.

HOLD

Current Price

$0.81

Market Cap

544.8K

Sector

Finance

ML Signal

HOLD

Logo Aditxt Inc.

ADTX

Aditxt Inc.

HOLD

Current Price

$1.37

Market Cap

641.6K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGHL
ADTX
Founded
2015
2017
Country
Singapore
United States
Employees
10
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
544.8K
641.6K
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LGHL
ADTX
Price
$0.81
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
139.4K
1.8M
Earning Date
04-30-2024
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.32
EPS
N/A
N/A
Revenue
N/A
$3,195.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.05
52 Week High
$8.92
$7.13

Technical Indicators

Market Signals
Indicator
LGHL
ADTX
Relative Strength Index (RSI) 47.55 72.92
Support Level $0.81 $0.80
Resistance Level $0.93 $1.84
Average True Range (ATR) 0.09 0.10
MACD 0.01 0.19
Stochastic Oscillator 44.71 70.65

Price Performance

Historical Comparison
LGHL
ADTX

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

Share on Social Networks: